癌性疼痛直接影响患者的生活质量和抗癌信心。我科自1999年10月开始，应用北京萌蒂制药有限公司生产的镇痛药物双克因控释片（酒石酸二氢可待因）治疗30例中度慢性癌痛患者，现报告如下。1 材料与方法t病例选择 本组30例患者中，男性19例，女性11例，年龄31~75岁，平 Cancerous pain directly affects the patient’s quality of life and cancer confidence. Since October 1999, our department has applied 30 patients with moderate chronic cancer pain treated with analgesic drug DiKeine controlled-release tablet (dihydrocodeine tartrate) produced by Beijing Mengti Pharmaceutical Co., Ltd., as reported below. 1 Materials and methods t Case selection In this group of 30 patients, 19 were male and 11 were female, aged 31 to 75 years old.